Iran medicine Archives - Iran News Daily

Iranian flu vaccine to commercialize

reporter 1222 — Mon, 10 Feb 2020 06:31:15 +0000

TEHRAN (Iran News) – CEO of a knowledge-based company said Iranian flu vaccine will hit the market in a few months after obtaining the necessary permits.

Speaking to Mehr News Agency on Sunday, Dr. Esmaeil Saberfar, CEO of an Iranian knowledge-based company active in producing flu vaccines, said his company obtained the technical know-how for the development of the vaccine after ten years of research and experiment.

“Manufacturers of this type of vaccine are in France, Germany, Belgium, the US, Italy, Japan, and South Korea; foreign-made flu vaccines are currently being used in the country,” he said.

According to him, about $8 million worth of these vaccines is imported annually, adding that the domestic production of the vaccines would save the country the same amount of forex.

“Although the vaccine has not yet been mass-produced, other countries such as India, Pakistan and the United Arab Emirates have already made a request for it,” he added.

The Iranian flu vaccine can rival those manufactured by France, he said, adding that the vaccine would hit the Iranian market in September 2020.

The post Iranian flu vaccine to commercialize appeared first on Iran News Daily.

Iran Made Edaravone Alsava for ALS patients

reporter 1222 — Sun, 12 Jan 2020 12:09:56 +0000

TEHRAN (Iran News) –The medicine of Edaravone Alsava for ALS (amyotrophic lateral sclerosis) patients was unveiled on Sunday morning in the presence of Iran’s Vice President for Science and Technology.

The medicine for patients with Amyotrophic Lateral Sclerosis (ALS) was unveiled in the form of Edaravone Alsava injection vials by a knowledge-based company in the Growth Center of Iran University of Medical Sciences (IUMS).

It is for two months that the medicine has hit the domestic consumer market and about 50 patients have used it.

Edaravone Injection Vial is a thick product that is prescribed for patients with ALS.

ALS disease causes the destruction of mobile cells in the spinal cord and is considered as a type of degenerative disease.

Statistics showed that 10 and 90 percent of patients with ALS have either been genetically or diagnosed with the disease respectively.

According to neurologists, the ALS disease is a degenerative disease that cannot be cured.

The post Iran Made Edaravone Alsava for ALS patients appeared first on Iran News Daily.

Shortage of Medicine in Iran Denied: Iran Minister

reporter 1222 — Tue, 10 Dec 2019 08:34:26 +0000

TEHRAN (Iran News) – There is no serious shortage of medicine or medical equipment in Iran, Minister of Health Saeed Namaki said.

Speaking to reporters on Monday, the health minister said Iran has not faced any severe shortage of medicine although the enemies have waged an economic war against the country.

The medicine shortage at the present time has dropped to one-third what it used to be last year, Namaki added.

Unveiling plans to inaugurate 1,000 new health and medical projects, he said the Health Ministry has launched the second stage of a grand plan focusing on the prevention of diseases.

In comments in October, Namaki said Iran was exporting pharmaceuticals to countries in Europe, Africa, and Central Asia.

Earlier in September, Secretary of Biotechnology Development Headquarter at the Iranian Vice-Presidency for Science and Technology said Iranian biopharmaceuticals were being exported to major customers like Russia, Iraq, Syria, Pakistan, Malaysia, and Turkey, adding that plans were underway to transfer Iranian biopharmaceuticals technology to Argentina.

The Independent News reported earlier that US sanctions have seriously impacted humanitarian trade with Iran, limiting the import of life-saving medicine into the country and endangering the lives of Iranian patients, according to a new report.

The report conducted by Human Rights Watch says patients in Iran suffering from special and rare diseases, such as cancer and epilepsy, dependent on imported medicine and therefore are suffering from the negative effects of sanctions.

The post Shortage of Medicine in Iran Denied: Iran Minister appeared first on Iran News Daily.

Iran-Made medicines en route to Russia

reporter 1222 — Wed, 27 Nov 2019 06:00:44 +0000

TEHRAN (Iran News) – Seventeen Iran-made medicines, containing high-tech drugs, will be exported to Russia, Mohsen Asadi Lari, director of international cooperation at the Ministry of Health, has announced.

Since last year, negotiations are underway with the Russian Ministry of Health for medicine trade, he said, adding that a meeting was also held in Moscow last week in this regard, IRNA reported on Tuesday.

The meeting was held on November 20, attended by deputy health ministers of Iran and Russia in line with the goal of cooperation and within the framework of a daylong seminar on the rules and procedures of registration of medicines and medical equipment in Russia.

There has been cooperation between the two countries for nearly five years in the field of medicine and medical equipment, he said, adding, Russia has a huge $20 billion drug market and Iran plans to expand cooperation with the neighboring country.

If companies reach an agreement on technology transfer, the production line could also be moved to the target country, for example, an Iranian pharmaceutical raw material production line started in Saint Petersburg three years ago, he highlighted.

He went on to say that entering the Eurasian health market can come beneficial for the country as Iran’s quality of medicine and medical equipment will prove high-quality in the region, adding, the country’s needs for pharmaceutical raw materials can also be met by attending these markets.

For the time being, Iran cooperates with Iraq, Lebanon and Tunisia in the health sector, he concluded.

Three years ago, Iran and Russia signed 15 documents, protocols and memorandums of understanding, focusing on the pharmaceutical and medical equipment sector.
Also, Iran has launched a production line for manufacturing multiple sclerosis drug in St. Petersburg.

Deputy health minister Reza Malekzadeh said in July that 73 types of Iran-made medicine produced by knowledge-based companies are being exported to other countries.

In late May, Hossein Vatanpur, an official with the Ministry of Health, announced that 52 Iranian knowledge-based companies export their products with value more than 70 million dollars.

The post Iran-Made medicines en route to Russia appeared first on Iran News Daily.

US sanction hampers Iran’s medicine import

reporter 1222 — Sun, 24 Nov 2019 05:03:47 +0000

TEHRAN (Iran News) – Iran’s Vice President and Head of the Plan and Budget Organization Mohammad Baqer Nobakht lashed out at Washington’s economic terrorism against his country, reminding that Iran’s medicine import is facing hardships to supply needed food and medication at the same time that it is banned from selling oil.

Nobakht said on Saturday that the US have created obstacles for Iran’s medicine and food import, adding that they have attempted to prevent export of a single barrel of oil as well, Fars News Agency reported.

The Iranian official said that the enemies have intensified sanctions against Iran.

Earlier this month, it was announced by an NGO that Iranian children suffering from epidermolysis bullosa (EB) are the new victims of inhumane US sanctions against Tehran, as Washington’s bans are preventing a Swedish supplier from sending protective bandages to the country.

Hamidreza Hashemi-Golpayegani, the head of the NGO that helps such patients, said on November 10 that at least 15 Iranian children with EB have died since the US launched its new sanctions on Iran in August.

Often known as butterfly children because their skin is as fragile as the wings of a butterfly, EB patients need special care. Even mild frictions or bumps cause severe blistering of the skin which is very painful.

The trade of humanitarian goods, such as food, medicine and medical devices, is on paper allowed by the US, still European companies refuse to do business with Iran, fearing secondary American sanctions.

Since the re-imposition of sanctions, Swedish medical products firm Molnlycke Health Care has stopped delivering Mepilex dressings which are trusted around the world to treat a wide range of chronic and acute wounds, including in EB patients, Iranian media reports say.

Human Rights Watch said in October that American sanctions against Iran have drastically constrained the country’s ability to pay for humanitarian imports and are threatening the health rights of Iranians.

US President Donald Trump unilaterally withdrew from the 2015 Iran nuclear deal last year and re-imposed punitive sanctions as part of a stated campaign of “maximum pressure” against the Islamic Republic.

Officially, the sanction regime makes exceptions for food, medicine and other humanitarian goods, but most companies are unwilling to do any trade with Iran for fear of repercussions in the world’s largest economy.

This is while, the United States insists that medicines and humanitarian goods are exempt from sanctions. The restrictions on trade have made many banks and companies across the world hesitant to do business with Iran, fearing punitive measures from Washington. The country is cut off from the international banking system.

Official reports say Iran produces some 95% of the basic medicines it needs and even exports some of the production to neighboring countries.

But when it comes to more sophisticated medication and medicines for costly and rare illnesses and medical equipment, Iran depends heavily on imports. And though the state provides health care for all, many treatments needed for complicated cases are simply not available.

Trump “administration officials claim they stand with the Iranian people, but the overbroad and burdensome US sanctions regime is harming Iranian’s right to health, including access to live-saving medicines”, Sarah Leah Whitson, Middle East director at HRW said on October 29.

“The comprehensive web of US sanctions has led banks and companies to pull back from humanitarian trade with Iran, leaving Iranians who have rare or complicated diseases unable to get the medicine and treatment they require,” she added.

Iranian patients have struggled with a foreign medicine shortage and price hikes for over a year both due to re-imposed US sanctions.

Medicine importers get subsidized currency rates from the government, yet foreign drugs and medical equipment cannot always be found in state-owned pharmacies.

The post US sanction hampers Iran’s medicine import appeared first on Iran News Daily.

Iran’s Self-Sufficiency in Medications is a Need

reporter 1222 — Thu, 07 Nov 2019 12:00:36 +0000

TEHRAN (Iran News) – Iranian Deputy Minister of Health, Treatment and Medical Education Mohammad Reza Shanehsaz emphasized that the country is able to produce nearly all its needed medicine despite the US sanctions. Iran’s self-sufficiency in medications is an achievement needed to be accomplished.

Iran is currently able to produce %99 of medicine needed by patients with the remaining one percent either not being cost-effective to be produced domestically or it is a totally new product in the world, Shanehsaz said, addressing the 16th Conference on Iran’s Pharmaceutical Sciences in Kermanshah on Wednesday.

He added that some 180 medicines will be produced in Iran within two years, which will save 250 million dollars in the currency for the country.

“Currently, Iran has a special status in terms of scientific products in the field of pharmaceuticals, which is indebted to the efforts of the local experts and elites,” Shanehsaz said.

While the enemies are seeking to create problems for the country, it has attained self-sufficiency in producing medicine, he said, noting that there is no shortage of medicine despite sanctions and pressure piled on the country.

Iran has taken long strides in producing different types of drugs and medical equipment and exported them to many foreign states.

A recent report by the scientific and technological department of Iran’s presidential office said that the country is able to produce 97% of its needs to drugs indigenously.

in July, Iranian Vice-President for Science and Technology Sorena Sattari unveiled 8 new drugs during his visit to knowledge-based companies in Alborz province near Tehran.

The newly-developed drugs included Micro-Peltamparazole, Tamsulosin hydrochloride, Naltrexone base, Citalyptin phosphate, Peo glitazone, and other medicine.

As a result of Iran’s self-sufficiency in medications, the drugs have applications in the treatment of digestive diseases and intestinal insufficiency, and will also be exported to the regional states.

The post Iran’s Self-Sufficiency in Medications is a Need appeared first on Iran News Daily.

Iran medicine imports affected by U.S sanctions

reporter 1222 — Wed, 30 Oct 2019 05:07:04 +0000

TEHRAN (Iran News) – Foreign Minister Mohammad Zarif said on Sunday that the new U.S. regulations is even targeting Iran medicine imports.

“Now, U.S. Treasury is targeting not merely food but also our imports of medicine,” Zarif tweeted.

In a move that the Treasury Department claimed would ease the shipment of food and medicine into Iran for humanitarian reasons, the Trump administration has announced a move to establish a system of “permissible trade.”

There was never any legal basis for restricting humanitarian aid under U.S. law, though U.S. hostility toward any shipment of anything to Iran made it de facto all but impossible, and banking statements scared many away from even trying.

Statements from NGOs were quick to criticize the effort, saying that far from clearing the way to allow such aid shipments, the U.S. was likely making it even harder to accomplish with new regulations from the Treasury Department.

To send aid to Iran, the Treasury Department will demand institutions submit “substantial and unprecedented” information, all invoices and details of all customers, and whether any of them were on U.S., EU, or UN blacklists.

Zarif said, “Contrary to its deceptive claims, new U.S. regulations will aggravate economic terrorism on ordinary Iranians.”

This is enough of a hassle that some analysts are predicting that there will be “not a single banker in the world” willing to accept these new conditions, and subsequently, it will have a chilling effect on aid, according to antiwar.com.

In his Sunday tweet, Zarif said U.S. Secretary of State Mike Pompeo “voiced his delusion that Iranian people must bow to the U.S. “if they want to eat”. It emphasizes the fact of targeting Iran medicine imports.

The post Iran medicine imports affected by U.S sanctions appeared first on Iran News Daily.